Biharee A - Search Results

1

Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach.

Devi N, Kaur K, Biharee A, Jaitak V. Devi N, et al. Among authors: biharee a. Anticancer Agents Med Chem. 2021;21(14):1802-1824. doi: 10.2174/1871520621999210104192644. Anticancer Agents Med Chem. 2021. PMID: 33397272 Review.

2

Antimicrobial Terpenoids as a Potential Substitute in Overcoming Antimicrobial Resistance.

Sharma A, Biharee A, Kumar A, Jaitak V. Sharma A, et al. Among authors: biharee a. Curr Drug Targets. 2020;21(14):1476-1494. doi: 10.2174/1389450121666200520103427. Curr Drug Targets. 2020. PMID: 32433003 Review.

3

Antimicrobial flavonoids as a potential substitute for overcoming antimicrobial resistance.

Biharee A, Sharma A, Kumar A, Jaitak V. Biharee A, et al. Fitoterapia. 2020 Oct;146:104720. doi: 10.1016/j.fitote.2020.104720. Epub 2020 Sep 7. Fitoterapia. 2020. PMID: 32910994 Review.

4

Recent Advancement of Polymersomes as Drug Delivery Carrier.

Singh K, Biharee A, Vyas A, Thareja S, Jain AK. Singh K, et al. Among authors: biharee a. Curr Pharm Des. 2022;28(20):1621-1631. doi: 10.2174/1381612828666220412103552. Curr Pharm Des. 2022. PMID: 35418282 Review.

5

Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations.

Biharee A, Yadav A, Jangid K, Singh Y, Kulkarni S, Sawant DM, Kumar P, Thareja S, Jain AK. Biharee A, et al. J Biomol Struct Dyn. 2023 Sep-Oct;41(16):7835-7846. doi: 10.1080/07391102.2022.2126397. Epub 2022 Sep 27. J Biomol Struct Dyn. 2023. PMID: 36165610

6

Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis.

Gupta K, Gautre P, Biharee A, Singh Y, Patil UK, Kumar S, Thareja S. Gupta K, et al. Among authors: biharee a. Med Oncol. 2024 Feb 24;41(4):81. doi: 10.1007/s12032-024-02325-5. Med Oncol. 2024. PMID: 38400892

7

An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.

Biharee A, Singh Y, Kulkarni S, Jangid K, Kumar V, Jain AK, Thareja S. Biharee A, et al. J Mol Graph Model. 2024 Mar;127:108695. doi: 10.1016/j.jmgm.2023.108695. Epub 2023 Dec 15. J Mol Graph Model. 2024. PMID: 38118354

8

Polycystic ovary syndrome: Current scenario and future insights.

Kulkarni S, Gupta K, Ratre P, Mishra PK, Singh Y, Biharee A, Thareja S. Kulkarni S, et al. Among authors: biharee a. Drug Discov Today. 2023 Dec;28(12):103821. doi: 10.1016/j.drudis.2023.103821. Epub 2023 Nov 5. Drug Discov Today. 2023. PMID: 37935329 Review.

9

Medicinal Aspects of PTP 1B Inhibitors as Anti-Breast Cancer Agents: An Overview.

Khator R, Biharee A, Bhatia N, Kulkarni S, Singh Y, Karthikeyan C, Jain AK, Thareja S. Khator R, et al. Among authors: biharee a. Curr Med Chem. 2023 Sep 14. doi: 10.2174/0929867331666230914103645. Online ahead of print. Curr Med Chem. 2023. PMID: 37711015

10

Developing our knowledge of the quinolone scaffold and its value to anticancer drug design.

Singh Y, Bhatia N, Biharee A, Kulkarni S, Thareja S, Monga V. Singh Y, et al. Among authors: biharee a. Expert Opin Drug Discov. 2023 Jul-Dec;18(10):1151-1167. doi: 10.1080/17460441.2023.2246366. Epub 2023 Aug 17. Expert Opin Drug Discov. 2023. PMID: 37592843 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page